Workflow
第三代试管婴儿技术
icon
Search documents
试管婴儿技术,只选对的,不选贵的
Xin Lang Cai Jing· 2025-12-24 23:57
Core Findings - A study led by Huang Hefeng, an academician from the Chinese Academy of Sciences, published in the British Medical Journal, indicates that for severe male infertility patients, the more expensive third-generation IVF technology does not show a higher live birth rate compared to the second-generation technology [1][2] - This conclusion provides critical evidence for international treatment guidelines and is expected to significantly reduce infertility treatment costs, benefiting more families [1] Group 1: Study Details - The research involved a multi-center randomized controlled trial conducted over several years at reproductive medicine centers including Zhejiang University, Fudan University, and Shanghai Jiao Tong University, with a total of 450 couples with severe male infertility [1] - Participants were divided into two groups: 225 couples received conventional second-generation IVF treatment, while 225 couples received second-generation IVF combined with third-generation technology [1] - Results showed no significant difference in live birth rates between the two groups for both the first embryo transfer and the cumulative live birth rate over one year [1] Group 2: Implications for Patients - Approximately 50 million individuals in China face infertility issues annually, with male factors accounting for 40% of these cases [2] - Many patients previously opted for the "higher-level" third-generation technology, which costs around 20,000 to 30,000 yuan per single test [2] - The study aims to help patients avoid unnecessary medical expenses, alleviate financial burdens, and correct misconceptions in the use of assisted reproductive technologies [2] - The principle emphasized is to choose the right technology rather than the more expensive one, ensuring the health and safety of offspring [2]
挤满生殖科的高龄夫妇,为什么非要生孩子?
36氪· 2025-10-12 13:34
Core Viewpoint - The article discusses the challenges and realities of assisted reproductive technology (ART) in China, emphasizing the importance of understanding fertility as a capability that may not last a lifetime, and the need for women to plan and make informed choices regarding reproduction [3][19][38]. Group 1: Assisted Reproductive Technology Overview - Assisted reproductive technology has rapidly developed over the past 40 years, with the first test-tube baby born in 1978 and the first in mainland China in 1988 [13]. - The success rate of assisted reproduction varies significantly with age, with women over 35 facing increased challenges in conceiving [15][17]. - The complete assisted reproductive cycle, including ovulation induction, egg retrieval, embryo transfer, and pregnancy maintenance, typically takes two to three months [8]. Group 2: Patient Demographics and Trends - There is a growing trend of older couples seeking ART services due to late marriage and childbearing, with many individuals unaware of the biological limitations of fertility [15][19]. - The incidence of infertility in China has increased from 12% in 2007 to 18% in 2020, highlighting a rising public health concern [28]. Group 3: Patient Experiences and Challenges - Many patients experience emotional and psychological stress during the ART process, often leading to anxiety about their fertility metrics [17][36]. - The article illustrates various patient stories, including those who have successfully conceived and those who have faced challenges, emphasizing the emotional journey involved in ART [19][38]. Group 4: Male Involvement in Fertility - Male fertility issues account for at least 30% of infertility cases, yet men often play a minimal role in the ART process [26][28]. - The article stresses the importance of male partners being actively involved in the fertility journey, as their support can significantly impact the emotional well-being of their partners [28]. Group 5: Medical and Social Perspectives on Infertility - The definition of infertility is complex, as many individuals diagnosed with infertility may not have other health issues, raising questions about the medicalization of fertility challenges [31][35]. - Cultural perceptions of fertility and motherhood can add pressure to women, influencing their emotional responses to infertility [36].